Short interest in Eterna Therapeutics Inc (NASDAQ:ERNA) decreased during the last reporting period, falling from 61.00K to 44.46K. This put 1.08% of the company's publicly available shares short.

Short interest for Eterna Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Eterna Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 43.38K shares traded per day, it would take 1.02 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.